← Back to Search

Behavioral: UR-GOAL communication tool for Acute Myeloid Leukemia

N/A
Waitlist Available
Research Sponsored by University of Rochester
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Newly diagnosed AML
Age ≥60 years (conventional definition of older age in AML)
Timeline
Screening 3 weeks
Treatment Varies
Follow Up four weeks
Awards & highlights

Study Summary

This trial will test a new communication tool to see if it is effective and easy to use for patients, caregivers, and oncologists when discussing treatment options for AML.

Eligible Conditions
  • Acute Myeloid Leukemia

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~four weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and four weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Feasibility (Recruitment Rates)
Usefulness
Secondary outcome measures
Pre-post Changes in the Following Outcomes: General Anxiety Disorder-7
Pre-post Changes in the Following Outcomes: Geriatric Depression Scale-15
Pre-post Changes in the Following Outcomes:Perceived Efficacy in Patient-Physician Interactions (PEPPI)

Trial Design

1Treatment groups
Experimental Treatment
Group I: Experimental: Experimental Arm: singleExperimental Treatment1 Intervention
The UR-GOAL tool will incorporate conjoint analysis to elicit patient preferences as well as assessments of fitness and prognostic awareness.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Behavioral: UR-GOAL communication tool
2021
N/A
~20

Find a Location

Who is running the clinical trial?

University of RochesterLead Sponsor
836 Previous Clinical Trials
518,331 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
A Patient-centered Communication Tool (UR-GOAL) for Older Patients With Acute Myeloid Leukemia, Their Caregivers, and Their Oncologists
Kah Poh Loh 2021. "A Patient-centered Communication Tool (UR-GOAL) for Older Patients With Acute Myeloid Leukemia, Their Caregivers, and Their Oncologists". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04625413.
~4 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top